T Cell Receptor Immunotherapy Targeting NY-ESO-1 for Patients With NY-ESO-1 Expressing Cancer
Clinical trial NCT01967823 · COMPLETED
Trial details
- NCT number
- NCT01967823
- Sponsor
- National Cancer Institute (NCI)
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2013-10-24
- Primary completion
- 2020-04-06
- Enrollment
- 11
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.